Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Opinion: When will we stop using Black bodies as research subjects?

Opinion: When will we stop using Black bodies as research subjects?

Neutral The San Diego Union-Tribune - California
Owner: Randall D. Smith & Heath Freeman
Valdo Calocane was free to carry out his killing spree after 'mental health workers feared detaining him would be racist', inquiry told

Valdo Calocane was free to carry out his killing spree after 'mental health workers feared detaining him would be racist', inquiry told

Right-wing GB News
Owner: Paul Marshall
Guinea-Bissau halts US-funded hepatitis B vaccine trial amid ethical concerns

Guinea-Bissau halts US-funded hepatitis B vaccine trial amid ethical concerns

Five things for pharma marketers to know for Tuesday, February 24, 2026

Five things for pharma marketers to know for Tuesday, February 24, 2026

Guinea-Bissau stops vaccine study funded by Trump administration

Guinea-Bissau stops vaccine study funded by Trump administration

Guinea-Bissau vaccine trial bucks precedent and international ethics standards, says WHO

Guinea-Bissau vaccine trial bucks precedent and international ethics standards, says WHO

WATCH | Guinea-Bissau stops vaccine study funded by Trump administration

WATCH | Guinea-Bissau stops vaccine study funded by Trump administration

UN agency recognizes 13 Guinea-Bissau communities as "FAO Villages"

WHO sets out concerns over US vaccine trial in G.Bissau

WHO sets out concerns over US vaccine trial in G.Bissau

Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

The Trump admin keeps citing unreviewed vaccine trial proposals in its call for ‘better science’

The Trump admin keeps citing unreviewed vaccine trial proposals in its call for ‘better science’

Voter ID Requirements Across the Globe Shatter Democrat Narratives

Voter ID Requirements Across the Globe Shatter Democrat Narratives

Right-wing The Daily Signal - Washington D.C.
Owner: The Heritage Foundation
Outrage of the Month: CDC Funding of a Troubling Guinea-Bissau Hepatitis B Vaccine Study

Outrage of the Month: CDC Funding of a Troubling Guinea-Bissau Hepatitis B Vaccine Study

Left-wing Public Citizen
Owner: Public Citizen Foundation
Guinea-Bissau halts US-funded hepatitis B vaccine trial amid ethical concerns

Guinea-Bissau halts US-funded hepatitis B vaccine trial amid ethical concerns

Five things for pharma marketers to know for Tuesday, February 24, 2026

Five things for pharma marketers to know for Tuesday, February 24, 2026

Guinea-Bissau stops vaccine study funded by Trump administration

Guinea-Bissau stops vaccine study funded by Trump administration

Guinea-Bissau vaccine trial bucks precedent and international ethics standards, says WHO

Guinea-Bissau vaccine trial bucks precedent and international ethics standards, says WHO

WATCH | Guinea-Bissau stops vaccine study funded by Trump administration

WATCH | Guinea-Bissau stops vaccine study funded by Trump administration

UN agency recognizes 13 Guinea-Bissau communities as "FAO Villages"

WHO sets out concerns over US vaccine trial in G.Bissau

WHO sets out concerns over US vaccine trial in G.Bissau

Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

The Trump admin keeps citing unreviewed vaccine trial proposals in its call for ‘better science’

The Trump admin keeps citing unreviewed vaccine trial proposals in its call for ‘better science’

Voter ID Requirements Across the Globe Shatter Democrat Narratives

Voter ID Requirements Across the Globe Shatter Democrat Narratives

Outrage of the Month: CDC Funding of a Troubling Guinea-Bissau Hepatitis B Vaccine Study

Outrage of the Month: CDC Funding of a Troubling Guinea-Bissau Hepatitis B Vaccine Study

Opinion: When will we stop using Black bodies as research subjects?

Opinion: When will we stop using Black bodies as research subjects?

Valdo Calocane was free to carry out his killing spree after 'mental health workers feared detaining him would be racist', inquiry told

Valdo Calocane was free to carry out his killing spree after 'mental health workers feared detaining him would be racist', inquiry told

Babies as ‘guinea pigs’: A vaccine trial in Guinea-Bissau comes under intense scrutiny

Babies as ‘guinea pigs’: A vaccine trial in Guinea-Bissau comes under intense scrutiny

Show More

Video Stories

YouTube video thumbnail: Ramadan Celebrations in Libya Tempered by Soaring Prices and Shortage of Fuel
Play
Ramadan Celebrations in Libya Tempered by Soaring Prices and Shortage of Fuel
YouTube video thumbnail: Unicef Urges Speedier Aid to Madagascar After Cyclone
Play
Unicef Urges Speedier Aid to Madagascar After Cyclone
YouTube video thumbnail: Dozens Killed, Women and Children Abducted in Nigeria's Zamfara
Play
Dozens Killed, Women and Children Abducted in Nigeria's Zamfara
YouTube video thumbnail: Senegal in Turmoil After Student Protest Over Financial Aid
Play
Senegal in Turmoil After Student Protest Over Financial Aid

Video Title

Press Releases

Macao Polytechnic University’s Internationalisation Project “MPU Connect” Shortlisted for QS Reimagine Education Awards

Macao Polytechnic University’s Internationalisation Project “MPU Connect” Shortlisted for QS Reimagine Education Awards

Macao Polytechnic University’s Internationalisation Project “MPU Connect” Shortlisted for QS Reimagine Education Awards

Macao Polytechnic University’s Internationalisation Project “MPU Connect” Shortlisted for QS Reimagine Education Awards

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions